Surgery Ebit Per Revenue from 2010 to 2025
| SGRY Stock | USD 24.19 0.20 0.82% |
Ebit Per Revenue | First Reported 2010-12-31 | Previous Quarter 0.11199949 | Current Value 0.15 | Quarterly Volatility 0.05170623 |
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 87.3 M, Interest Expense of 154.1 M or Selling General Administrative of 520.6 M, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0014 or PTB Ratio of 1.57. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
Surgery | Ebit Per Revenue |
Latest Surgery Partners' Ebit Per Revenue Growth Pattern
Below is the plot of the Ebit Per Revenue of Surgery Partners over the last few years. It is Surgery Partners' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
| Ebit Per Revenue | 10 Years Trend |
|
Ebit Per Revenue |
| Timeline |
Surgery Ebit Per Revenue Regression Statistics
| Arithmetic Mean | 0.15 | |
| Geometric Mean | 0.14 | |
| Coefficient Of Variation | 34.09 | |
| Mean Deviation | 0.04 | |
| Median | 0.14 | |
| Standard Deviation | 0.05 | |
| Sample Variance | 0 | |
| Range | 0.1884 | |
| R-Value | (0.66) | |
| Mean Square Error | 0 | |
| R-Squared | 0.44 | |
| Significance | 0.01 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.04 |
Surgery Ebit Per Revenue History
About Surgery Partners Financial Statements
Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Ebit Per Revenue | 0.11 | 0.15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.